$BKIT back on radar! The team at Blake Insomnia Therapeutics, Inc. is attempting to reduce insomnia in patients with a patent-pending compound called Zleepax (ZLX-1). The treatment has demonstrated a high level of efficacy without the traditional side effects associated with current sleep medications. http://microcapdaily.net/blake-insomnia-therapeutics-otc-bkit/
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.